13631 PROGRESS BLVD., ALACHUA, FL
Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair
Amended material disclosure
Enters into Definitive Agreement to Acquire BioCircuit Technologies, Investor Presentation
Earnings Release
Shareholder Meeting Results: Directors Elected at Axogen, Inc.
Annual Report to Security Holders
Reports First Quarter 2026 Financial Results
Reports Fourth Quarter and Full-Year 2025 Financial Results
Q2
Q1
FY 2024
Q3
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Correspondence
Submission Upload
Post-Effective Amendment to Registration Statement